In The News: January 2014

Postmenopausal Drug Approved by FDA Aids Osteoporosis in SomeThe Food and Drug Administration (FDA) has approved a novel estrogen-based drug for women to treat moderate-to-severe vasomotor symptoms associated with menopause as well as prevent postmenopausal osteoporosis. The new drug for menopausal women (Duavee) is the first to combine conjugated estrogens with bazedoxifene. Bazedoxifene is approved in Europe for the prevention of osteoporosis and has been shown to reduce the risk of endometrial hyperplasia, a possible…
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access